Wang Q, Lang J, Zhi Y, Zhu X, Fu Y
J Assist Reprod Genet. 2025; .
PMID: 39806215
DOI: 10.1007/s10815-024-03386-1.
Neves A, Garcia S, Vuong L, Blockeel C, Spits C, Polyzos N
Reprod Sci. 2024; 31(11):3560-3568.
PMID: 39322797
DOI: 10.1007/s43032-024-01700-x.
Li Y, Zhang S, Zhang C
J Ovarian Res. 2024; 17(1):174.
PMID: 39198856
PMC: 11351649.
DOI: 10.1186/s13048-024-01491-4.
Jiesisibieke D, Tian T, Zhu X, Fang S, Zhang N, Ma J
Reprod Sci. 2024; 31(5):1353-1362.
PMID: 38228973
PMC: 11090916.
DOI: 10.1007/s43032-023-01444-0.
Correa N, Cerquides J, Arcos J, Vassena R, Popovic M
Trials. 2024; 25(1):38.
PMID: 38212837
PMC: 10782678.
DOI: 10.1186/s13063-024-07907-2.
Conventional follicular-phase ovarian stimulation vs. luteal-phase stimulation in suboptimal responders: a randomized controlled trial.
Sunol J, Castillo J, Ortiz J, Ten J, Fuentes A, Moliner B
F S Rep. 2024; 4(4):344-352.
PMID: 38204945
PMC: 10774905.
DOI: 10.1016/j.xfre.2023.07.003.
Do we overlook predictive factors in Poseidon 1 patients? A retrospective analysis co-evaluating antral follicle counts & diameters.
Uncu G, Aslan K, Cakir C, Avci B, Kasapoglu I, Alviggi C
J Ovarian Res. 2024; 17(1):1.
PMID: 38169411
PMC: 10759700.
DOI: 10.1186/s13048-023-01323-x.
Cut-off point of mature oocyte for routine clinical application of rescue IVM: a retrospective cohort study.
Wei J, Luo Z, Dong X, Jin H, Zhu L, Ai J
J Ovarian Res. 2023; 16(1):226.
PMID: 37993915
PMC: 10664607.
DOI: 10.1186/s13048-023-01294-z.
Efficacy of Artificial Oocyte Activation in Improving the Reproductive Outcome in Poor Responders: A Single Centre Cohort Study.
Kaur B, Malik S, Prakash V, Bhatia V, Gupta D
J Family Reprod Health. 2023; 17(1):45-53.
PMID: 37538231
PMC: 10394489.
DOI: 10.18502/jfrh.v17i1.11977.
Involvement of SYCP2L and TDRD3 gene variants on ovarian reserve and reproductive outcomes: a cross-sectional study.
Rosa I, Barbosa C, Ferrandez C, Sonoda B, Christofolini D, Trevisan C
JBRA Assist Reprod. 2023; 27(3):428-435.
PMID: 37417852
PMC: 10712833.
DOI: 10.5935/1518-0557.20220074.
POvaStim: An online tool for directing individualized FSH doses in ovarian stimulation.
Xu H, Feng G, Han Y, La Marca A, Li R, Qiao J
Innovation (Camb). 2023; 4(2):100401.
PMID: 36926531
PMC: 10011821.
DOI: 10.1016/j.xinn.2023.100401.
Poor ovarian response is associated with air pollutants: A multicentre study in China.
Wu S, Hao G, Zhang Y, Chen X, Ren H, Fan Y
EBioMedicine. 2022; 81:104084.
PMID: 35660784
PMC: 9163489.
DOI: 10.1016/j.ebiom.2022.104084.
Regulation of antral follicular growth by an interplay between gonadotropins and their receptors.
Casarini L, Paradiso E, Lazzaretti C, DAlessandro S, Roy N, Mascolo E
J Assist Reprod Genet. 2022; 39(4):893-904.
PMID: 35292926
PMC: 9050977.
DOI: 10.1007/s10815-022-02456-6.
Fresh elective frozen embryo transfer: Cumulative live birth rates of 7,236 IVF cycles.
Le T, Ong P, Nguyen Q, Roque M
JBRA Assist Reprod. 2022; 26(3):450-459.
PMID: 35191632
PMC: 9355431.
DOI: 10.5935/1518-0557.20210094.
What Does Unexpected Suboptimal Response During Ovarian Stimulation Suggest, an Overlooked Group?.
Wang B, Liu W, Liu Y, Zhang W, Ren C, Guan Y
Front Endocrinol (Lausanne). 2022; 12:795254.
PMID: 35002973
PMC: 8727549.
DOI: 10.3389/fendo.2021.795254.
Impact of Ovarian Yield-Number of Total and Mature Oocytes Per Antral Follicular Count-On Live Birth Occurrence After IVF Treatment.
Poulain M, Younes R, Pirtea P, Trichereau J, de Ziegler D, Benammar A
Front Med (Lausanne). 2021; 8:702010.
PMID: 34504852
PMC: 8421602.
DOI: 10.3389/fmed.2021.702010.
Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as part of medically-assisted reproduction in clinical studies: a systematic review covering 10 years (2007-2017).
Fatemi H, Bilger W, Denis D, Griesinger G, La Marca A, Longobardi S
Reprod Biol Endocrinol. 2021; 19(1):68.
PMID: 33975610
PMC: 8112039.
DOI: 10.1186/s12958-021-00744-x.
Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis.
Chua S, Mol B, Longobardi S, Orvieto R, Venetis C, Lispi M
Reprod Biol Endocrinol. 2021; 19(1):51.
PMID: 33794909
PMC: 8017804.
DOI: 10.1186/s12958-021-00727-y.
Fresh and cumulative live birth rates in mild versus conventional stimulation for IVF cycles in poor ovarian responders: a systematic review and meta-analysis.
Montoya-Botero P, Drakopoulos P, Gonzalez-Foruria I, Polyzos N
Hum Reprod Open. 2021; 2021(1):hoaa066.
PMID: 33614987
PMC: 7882043.
DOI: 10.1093/hropen/hoaa066.
Growth hormone supplementation during ovarian stimulation improves oocyte and embryo outcomes in IVF/PGT-A cycles of women who are not poor responders.
Skillern A, Leonard W, Pike J, Mak W
J Assist Reprod Genet. 2021; 38(5):1055-1060.
PMID: 33534048
PMC: 8190221.
DOI: 10.1007/s10815-021-02088-2.